# The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients

> **NCT06935942** · — · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 906 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** Ustekinumab - Standard Dosage

## Key facts

- **NCT ID:** NCT06935942
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 906 (ACTUAL)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935942, "The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06935942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*